|
[Related PubMed/MEDLINE]
Total Number of Papers: 240
|
|
|
| |
|
[Display Entries]
|
|
>> all entries
|
| |
|
[Entries Per Page]
|
|
per page
|
| |
|
Page Control
|
|
|
| Page: of |
|
|
|
| No. |
Year |
Title |
Co-occurring Abbreviation |
| 1 |
2020 |
A Retrospective Biopharmaceutical Analysis of >800 Approved Oral Drug Products: Are Drug Properties of Solid Dispersions and Lipid-Based Formulations Distinctive? |
LBF |
| 2 |
2020 |
Albendazole solid dispersions prepared using PEG6000 and Poloxamer188: formulation, characterization and invivo evaluation. |
ABZ, AUCs, FTIR, PEG 6000, PXRD, SEM |
| 3 |
2020 |
Benznidazole/Poloxamer 407 Solid Dispersion as a New Strategy to Improve the Treatment of Experimental Trypanosoma cruzi Infection. |
CF |
| 4 |
2020 |
Calcitriol tablets with hybrid lipid-based solid dispersions with enhanced stability and content uniformity. |
HLC |
| 5 |
2020 |
Clarification of the Dissolution Mechanism of an Indomethacin/Saccharin/Polyvinylpyrrolidone Ternary Solid Dispersion by NMR Spectroscopy. |
IMC, PVP, SAC |
| 6 |
2020 |
Development of binary dispersions and nanocomposites of irbesartan with enhanced antihypertensive activity. |
DSC, FE-SEM, FTIR, IBS, NC, SEM, TEM, XRD |
| 7 |
2020 |
Evaluation of the Solid Dispersion System Engineered from Mesoporous Silica and Polymers for the Poorly Water Soluble Drug Indomethacin: In Vitro and In Vivo. |
DSC, FESEM, HPMC, IMC, IR, MSNs, PAMPA, PIs, PXRD |
| 8 |
2020 |
Formulation strategy of nitrofurantoin: co-crystal or solid dispersion? |
ATR-FTIR, DSC, HPMC, NF |
| 9 |
2020 |
Improvement in the Oral Bioavailability and Efficacy of New Ezetimibe Formulations-Comparative Study of a Solid Dispersion and Different Micellar Systems. |
DSC, EZ, EZ-RM, MS, PXRD, SEM |
| 10 |
2020 |
Manufacturing strategies to develop amorphous solid dispersions: An overview. |
--- |
| 11 |
2020 |
Oral Bioavailability Enhancement and Anti-Fatigue Assessment of the Andrographolide Loaded Solid Dispersion. |
AG |
| 12 |
2020 |
Preparation and Characterization of Griseofulvin Solid Dispersions. |
GSV, IR, PM, PVP |
| 13 |
2020 |
Preparation and evaluation of a novel solid dispersion using leucine as carrier. |
Leu, OA |
| 14 |
2020 |
Preparation of Hot-Melt Extruded Dosage Form for Enhancing Drugs Absorption Based on Computational Simulation. |
API, HME, PBPK, PSA |
| 15 |
2020 |
Solid Dispersion Pellets: An Efficient Pharmaceutical Approach to Enrich the Solubility and Dissolution Rate of Deferasirox. |
DFX, DSC, FTIR, PEG 4000, SEM, XRD |
| 16 |
2020 |
Solubilization of phloretin via steviol glycoside-based solid dispersion and micelles. |
MC, PT, SA, STE |
| 17 |
2020 |
Spray dried solid dispersion of repaglinide using hypromellose acetate succinate: invitro and invivo characterization. |
HPMCAS, SDSD |
| 18 |
2020 |
The Effect of Cooling on the Degree of Crystallinity, Solid-State Properties, and Dissolution Rate of Multi-Component Hot-Melt Extruded Solid Dispersions. |
DSC, INM, PL-S630, XRPD |
| 19 |
2019 |
Amorphous multi-system of celecoxib improves its anti-inflammatory activity in vitro and oral absorption in rats. |
BA, CXB, DW, SLS |
| 20 |
2019 |
Comparison of paclitaxel solid dispersion and polymeric micelles for improved oral bioavailability and in vitro anti-cancer effects. |
BA, MDCK line, PTX, TPGS |
| 21 |
2019 |
Cooperative effect of polyvinylpyrrolidone and HPMC E5 on dissolution and bioavailability of nimodipine solid dispersions and tablets. |
FB-T, NMP, PVP |
| 22 |
2019 |
Design of Coenzyme Q10 solid dispersion for improved solubilization and stability. |
CQ10 |
| 23 |
2019 |
Development of a Ternary Solid Dispersion Formulation of LW6 to Improve the In Vivo Activity as a BCRP Inhibitor: Preparation and In Vitro/In Vivo Characterization. |
BCRP, DSC, FTIR, SEM, XRPD |
| 24 |
2019 |
Development of solid dispersion lipid nanoparticles for improving skin delivery. |
CUR, SD-SLNs, SLNs |
| 25 |
2019 |
Drug-polymer miscibility, interactions, and precipitation inhibition studies for the development of amorphous solid dispersions for the poorly soluble anticancer drug flutamide. |
FLT, MDSC, PM, PXRD |
| 26 |
2019 |
Effect of Carrier Lipophilicity and Preparation Method on the Properties of Andrographolide⁻Solid Dispersion. |
AG, PEG, Tm |
| 27 |
2019 |
Formulation of aripiprazole-loaded pH-modulated solid dispersions via hot-melt extrusion technology: In vitro and in vivo studies. |
ARI, DSC, HME, SA, SEM, XRD |
| 28 |
2019 |
Highly Water-Soluble Solid Dispersions of Honokiol: Preparation, Solubility, and Bioavailability Studies and Anti-Tumor Activity Evaluation. |
AGJ, AIJ, HK, PLX |
| 29 |
2019 |
Improvement of the dissolution rate and bioavailability of fenofibrate by the supercritical anti-solvent process. |
AUC, CSE, SAS |
| 30 |
2019 |
Improving solubility and dissolution of meloxicam by solid dispersion using hydroxypropyl methylcellulose 2910 3 cps and nicotinamide. |
DTA, HPMC, MLX, NC, PXRD, SEM |
| 31 |
2019 |
Insight into the Dissolution Molecular Mechanism of Ternary Solid Dispersions by Combined Experiments and Molecular Simulations. |
DSC, GLI, IR, MD, SEM, XRD |
| 32 |
2019 |
Naftopidil-fumaric acid interaction in a solid dispersion system: Improving the dissolution rate and oral absorption of naftopidil in rats. |
NAF |
| 33 |
2019 |
Predicting physical stability of solid dispersions by machine learning techniques. |
ED, RF |
| 34 |
2019 |
Preparation of Liquid Oral Mucoadhesive Gastro-retentive System of Nimodipine. |
--- |
| 35 |
2019 |
Preparation, characterization and ex vivo-in vivo assessment of candesartan cilexetil nanocrystals via solid dispersion technique using an alkaline esterase activator carrier. |
CC |
| 36 |
2019 |
Preparation, physicochemical and pharmacological study of curcumin solid dispersion with an arabinogalactan complexation agent. |
AG, CUR, GPC |
| 37 |
2019 |
Solid Dispersion of Kaempferol: Formulation Development, Characterization, and Oral Bioavailability Assessment. |
AUC, DSC, FTIR, KPF, SEM, XRD |
| 38 |
2019 |
Solubility and bioavailability enhancement study of lopinavir solid dispersion matrixed with a polymeric surfactant - Soluplus. |
H-bond, HME, LPV, P-gp |
| 39 |
2019 |
T2 Relaxation Study to Evaluate the Crystalline State of Indomethacin Containing Solid Dispersions Using Time-Domain NMR. |
APIs, IMC, PM, PVP, TD-NMR |
| 40 |
2019 |
Ternary solid dispersion to improve solubility and dissolution of meloxicam. |
HPMC, MLX, NA |
| 41 |
2018 |
Application of scCO2 technology for preparing CoQ10 solid dispersion and SFC-MS/MS for analyzing in vivo bioavailability. |
DSC, PXRD, SEM |
| 42 |
2018 |
Association of Silver Nanoparticles and Curcumin Solid Dispersion: Antimicrobial and Antioxidant Properties. |
CUR |
| 43 |
2018 |
Crystalline Ethylene Oxide and Propylene Oxide Triblock Copolymer Solid Dispersion Enhance Solubility, Stability and Promoting Time- Controllable Release of Curcumin. |
CUR, HPMC K4M, PVP-K30 |
| 44 |
2018 |
Dissolution and oral bioavailability enhancement of praziquantel by solid dispersions. |
AUCs, FTIR, PZQ, SDS, XRD |
| 45 |
2018 |
Early formulation development of CKD-519, a new CETP inhibitor, for phase 1 clinical study based on in vitro and in vivo evaluation. |
CETP, SMEDDS |
| 46 |
2018 |
Encapsulation of Solid Dispersion in Solid Lipid Particles for Dissolution Enhancement of Poorly Water-Soluble Drug. |
SDSLs, SLs |
| 47 |
2018 |
Enhanced delivery of fixed-dose combination of synergistic antichagasic agents posaconazole-benznidazole based on amorphous solid dispersions. |
ASDs, AUC, BNZ, PCZ |
| 48 |
2018 |
Enhancement of Aqueous Solubility and Dissolution of Celecoxib through Phosphatidylcholine-Based Dispersion Systems Solidified with Adsorbent Carriers. |
CLC, FT-IR, PC |
| 49 |
2018 |
Enhancement of lymphatic transport of lutein by oral administration of a solid dispersion and a self-microemulsifying drug delivery system. |
SMEDDS |
| 50 |
2018 |
HPMCAS as an effective precipitation inhibitor in amorphous solid dispersions of the poorly soluble drug candesartan cilexetil. |
CC, HPMC, HPMCAS |
| 51 |
2018 |
Identification of molecular-interaction sites between lowly hydrolyzed polyvinyl alcohols and indomethacin by NMR spectroscopy. |
IND, NOESY, PVAs |
| 52 |
2018 |
Molecular-level elucidation of saccharin-assisted rapid dissolution and high supersaturation level of drug from Eudragit E solid dispersion. |
EUD-E, PHT, SAC |
| 53 |
2018 |
Preparation and comparison of tacrolimus-loaded solid dispersion and self-microemulsifying drug delivery system by in vitro/in vivo evaluation. |
HPMC, SMEDDS |
| 54 |
2018 |
Preparation of curcumin self-micelle solid dispersion with enhanced bioavailability and cytotoxic activity by mechanochemistry. |
CUR |
| 55 |
2018 |
Preparation of lapatinib ditosylate solid dispersions using solvent rotary evaporation and hot melt extrusion for solubility and dissolution enhancement. |
DSC, DT, HME, LB, PXRD, SEM, SRE |
| 56 |
2018 |
Preparation, characterization and in vitro and in vivo evaluation of a solid dispersion of Naringin. |
FT-IR, NA |
| 57 |
2018 |
Solid dispersion of dutasteride using the solvent evaporation method: Approaches to improve dissolution rate and oral bioavailability in rats. |
ATR FT-IR, BA, DSC, DUT, FESEM, MCC, PXRD, SLS, TPGS |
| 58 |
2018 |
Solid dispersions to enhance the delivery of a potential drug candidate LPSF/FZ4 for the treatment of schistosomiasis. |
--- |
| 59 |
2018 |
Synchronized release of bufadienolides in a stable Lutrol F127 based solid dispersion prepared with spray congealing. |
--- |
| 60 |
2017 |
Bioenhanced advanced third generation solid dispersion of tadalafil: Repurposing with improved therapy in pyelonephritis. |
PN, SMEC, TDL |
| 61 |
2017 |
Design of fixed dose combination and physicochemical characterization of enteric-coated bilayer tablet with circadian rhythmic variations containing telmisartan and pravastatin sodium. |
FDC, MgO, PEG 6000, PRA, TEL |
| 62 |
2017 |
Design of PVP/VA S-630 based tadalafil solid dispersion to enhance the dissolution rate. |
BCS, DW, FT-IR, SLS, TDF |
| 63 |
2017 |
Design, Optimization and Evaluation of Orally Disintegrating Tablet of Meloxicam Using Its Menthol Based Solid Dispersions. |
DSC, MLX, ODTs, PVP k30, SLS, XRD |
| 64 |
2017 |
Development of a binary carrier system consisting polyethylene glycol 4000 - ethyl cellulose for ibuprofen solid dispersion. |
API, ATR-FTIR, DSC, EC, PEG, SDP, SEM |
| 65 |
2017 |
Development, Physicochemical Characterization and In Vitro Anti-Inflammatory Activity of Solid Dispersions of alpha,beta Amyrin Isolated from Protium Oilresin. |
ABAM, DSC, FTIR, HPMC, KND, PM, RE, SEM, TG, XRD |
| 66 |
2017 |
Enhancement of solubility and dissolution rate of baicalein, wogonin and oroxylin A extracted from Radix scutellariae. |
VC |
| 67 |
2017 |
Enhancement of the aqueous solubility and permeability of a poorly water soluble drug ritonavir via lyophilized milk-based solid dispersions. |
DSC, FTIR, PXRD, RTV, SEM |
| 68 |
2017 |
Ginger Extract-Loaded Solid Dispersion System with Enhanced Oral Absorption and Antihypothermic Action. |
GE, GE |
| 69 |
2017 |
Improved Dissolution of Dipyridamole with the Combination of pH-Modifier and Solid Dispersion Technology. |
DP, TA |
| 70 |
2017 |
Polymeric behavior evaluation of PVP K30-poloxamer binary carrier for solid dispersed nisoldipine by experimental design. |
SDnisol |
| 71 |
2017 |
Role of P-Glycoprotein Inhibitors in the Bioavailability Enhancement of Solid Dispersion of Darunavir. |
DoE, DRV |
| 72 |
2017 |
Surface Solid Dispersion and Solid Dispersion of Meloxicam: Comparison and Product Development. |
CPV, MLX, SSD |
| 73 |
2017 |
Tadalafil solid dispersion formulations based on PVP/VA S-630: Improving oral bioavailability in rats. |
BA, TDF |
| 74 |
2016 |
A comparative study on the effects of amphiphilic and hydrophilic polymers on the release profiles of a poorly water-soluble drug. |
DL, FEN, PF127 |
| 75 |
2016 |
A silica-supported solid dispersion of bifendate using supercritical carbon dioxide method with enhanced dissolution rate and oral bioavailability. |
DSC, RH, XRD |
| 76 |
2016 |
Application of hot-melt extrusion technology for designing an elementary osmotic pump system combined with solid dispersion for a novel poorly water-soluble antidepressant. |
EOP, HME |
| 77 |
2016 |
Atorvastatin solid dispersion for bioavailability enhancement. |
AT |
| 78 |
2016 |
Characterization of Solid Dispersion of Itraconazole Prepared by Solubilization in Concentrated Aqueous Solutions of Weak Organic Acids and Drying. |
ATR-FTIR, DSC, ITZ, PXRD |
| 79 |
2016 |
Chitosan-based nano-in-microparticle carriers for enhanced oral delivery and anticancer activity of propolis. |
CS, NIMs, NPs |
| 80 |
2016 |
Development and evaluation of solid dispersion of spironolactone using fusion method. |
API, PEG 4000, SPL |
| 81 |
2016 |
Development and Optimization of Controlled Porosity Osmotic Tablets of Lamotrigine Solid Dispersion. |
CPOT |
| 82 |
2016 |
Dissolution enhancement of felodipine by amorphous nanodispersions using an amphiphilic polymer: insight into the role of drug-polymer interactions on drug dissolution. |
--- |
| 83 |
2016 |
Enhancement of Dissolution Rate and Intestinal Stability of Clopidogrel Hydrogen Sulfate. |
--- |
| 84 |
2016 |
Evaluation of physicochemical properties and in vivo efficiency of atorvastatin calcium/ezetimibe solid dispersions. |
ATV, DSC, EZT, PMs, PXRD, TC |
| 85 |
2016 |
Extruded Soluplus/SIM as an oral delivery system: characterization, interactions, in vitro and in vivo evaluations. |
HME, PMs, SIM |
| 86 |
2016 |
Formulation of cyclodextrin inclusion complex-based orally disintegrating tablet of eslicarbazepine acetate for improved oral bioavailability. |
beta-CD, DSC, ESL, FTIR, ODT, XRD |
| 87 |
2016 |
Hydrophilic-hydrophobic polymer blend for modulation of crystalline changes and molecular interactions in solid dispersion. |
--- |
| 88 |
2016 |
Improved oral absorption of tacrolimus by a solid dispersion with hypromellose and sodium lauryl sulfate. |
HPMC, SLS |
| 89 |
2016 |
Investigation of Polymer-Surfactant and Polymer-Drug-Surfactant Miscibility for Solid Dispersion. |
--- |
| 90 |
2016 |
Optimized sildenafil citrate fast orodissolvable film: a promising formula for overcoming the barriers hindering erectile dysfunction treatment. |
ODF |
| 91 |
2016 |
Physical characterization and dissolution performance assessment of Etravirine solid dispersions prepared by spray drying process. |
ANOVA, DSC, FTIR, MDT, SEM |
| 92 |
2016 |
Preparation and characterization of dipyridamole solid dispersions for stabilization of supersaturation: effect of precipitation inhibitors type and molecular weight. |
DPL, HPMC, PVP |
| 93 |
2016 |
Sodium alginate as a potential carrier in solid dispersion formulations to enhance dissolution rate and apparent water solubility of BCS II drugs. |
SA, TEL |
| 94 |
2016 |
Solid-state characterization of Felodipine-Soluplus amorphous solid dispersions. |
FEL, SOL |
| 95 |
2016 |
Solubilization and formulation of chrysosplenol C in solid dispersion with hydrophilic carriers. |
CRSP, DSC, FTIR, SEM, SLS, XRD |
| 96 |
2016 |
The improved dissolution performance of a post processing treated spray-dried crystalline solid dispersion of poorly soluble drugs. |
PVA |
| 97 |
2015 |
A (polyvinyl caprolactam-polyvinyl acetate-polyethylene glycol graft copolymer)-dispersed sustained-release tablet for imperialine to simultaneously prolong the drug release and improve the oral bioavailability. |
--- |
| 98 |
2015 |
Anomalous role change of tertiary amino and ester groups as hydrogen acceptors in eudragit E based solid dispersion depending on the concentration of naproxen. |
EGE, NAP, Tg |
| 99 |
2015 |
Controlled porosity solubility modulated osmotic pump tablets of gliclazide. |
CPOP, GLZ, HME |
| 100 |
2015 |
Conversion of solid dispersion prepared by acid-base interaction into free-flowing and tabletable powder by using Neusilin US2. |
--- |
|
A Search Service for Abbreviation / Long Form
